ResearcherHelmholtz MunichNo recent work listed
Axel Karl Walch
Matched on ORCID iD 0000-0001-5578-4023; OpenAlex author ID A5074211261. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers
Papers 6
- Functional metabolic phenotyping of human pancreatic ductal adenocarcinoma Co-author DOI 10.1101/2021.07.23.452145↗
- Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s13550-021-00862-y↗
- Modeling Therapy Response and Spatial Tissue Distribution of Erlotinib in Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-15-0165↗
- X-ray phase-contrast CT of a pancreatic ductal adenocarcinoma mouse model. Co-author DOI 10.1371/journal.pone.0058439↗
- MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0039424↗
- Nuclear position and shape deformation of chromosome 8 territories in pancreatic ductal adenocarcinoma. Co-author DOI 10.1155/2011/840696↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jens Thomas Siveke · 5 shared papers, 2012–2021 · strength 0.31
- Paper Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic du… DOI 10.1186/s13550-021-00862-y↗
- Paper Functional metabolic phenotyping of human pancreatic ductal adenocarcinoma DOI 10.1101/2021.07.23.452145↗
- Paper Modeling Therapy Response and Spatial Tissue Distribution of Erlotinib in Pancreatic Cancer. DOI 10.1158/1535-7163.mct-15-0165↗
- Marija Trajkovic‐Arsic · 4 shared papers, 2012–2021 · strength 0.26
- Paper Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic du… DOI 10.1186/s13550-021-00862-y↗
- Paper Functional metabolic phenotyping of human pancreatic ductal adenocarcinoma DOI 10.1101/2021.07.23.452145↗
- Paper X-ray phase-contrast CT of a pancreatic ductal adenocarcinoma mouse model. DOI 10.1371/journal.pone.0058439↗
- Iréne Esposito · 3 shared papers, 2012–2021 · strength 0.19
- Paper Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic du… DOI 10.1186/s13550-021-00862-y↗
- Paper Modeling Therapy Response and Spatial Tissue Distribution of Erlotinib in Pancreatic Cancer. DOI 10.1158/1535-7163.mct-15-0165↗
- Paper MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer. DOI 10.1371/journal.pone.0039424↗
- Rickmer Braren · 3 shared papers, 2013–2021 · strength 0.17
- Paper Functional metabolic phenotyping of human pancreatic ductal adenocarcinoma DOI 10.1101/2021.07.23.452145↗
- Paper Modeling Therapy Response and Spatial Tissue Distribution of Erlotinib in Pancreatic Cancer. DOI 10.1158/1535-7163.mct-15-0165↗
- Paper X-ray phase-contrast CT of a pancreatic ductal adenocarcinoma mouse model. DOI 10.1371/journal.pone.0058439↗
- Na Sun · 2 shared papers, 2016–2021 · strength 0.17
- Wilko Weichert · 1 shared paper, 2021 · strength 0.12
- Anna Melissa Schlitter · 1 shared paper, 2021 · strength 0.12
- Phyllis F. Cheung · 1 shared paper, 2021 · strength 0.09
- Andrea Tannapfel · 1 shared paper, 2021 · strength 0.09
- Erik H.J.G. Aarntzen · 1 shared paper, 2021 · strength 0.09
- Waldemar H. Uhl · 1 shared paper, 2021 · strength 0.09
- E. Smeets · 1 shared paper, 2021 · strength 0.09
- Irina Heid · 1 shared paper, 2021 · strength 0.09
- Stephan A. Hahn · 1 shared paper, 2021 · strength 0.09
- Laura Godfrey · 1 shared paper, 2021 · strength 0.09
- Jörg D. Hoheisel · 1 shared paper, 2021 · strength 0.09
- Smiths Lueong · 1 shared paper, 2021 · strength 0.09
- Michaela Aichler · 2 shared papers, 2013–2016 · strength 0.08
- Barbara M. Grüner · 2 shared papers, 2012–2016 · strength 0.08
- Roland Michael Schmid · 2 shared papers, 2012–2016 · strength 0.08
- Alexander Herner · 1 shared paper, 2016 · strength 0.05
- Arne Tapfer · 1 shared paper, 2013 · strength 0.03
- Franz Pfeiffer · 1 shared paper, 2013 · strength 0.03
- Sylvia Timme · 1 shared paper, 2011 · strength 0.03
- Bernhard Küster · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.